| Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442) |
|---|
| 10/18/2005 | US6956124 from 4-acetoxy-2 alpha -benzoyloxy-5 beta ,20-epoxy-1,13 alpha -dihydroxy-9-oxo-7 beta -(trifluoromethyl sulfonyloxy) tax-11-ene by reaction with a molecular sieve in sulfolane |
| 10/18/2005 | US6956123 Purification of taxanes and taxane mixtures using polyethyleneimine-bonded resins |
| 10/13/2005 | WO2005095356A1 Agent for generating heat or singlet oxygen and composition for cancer treatment each comprising organic peroxide or chemiluminescent compound |
| 10/13/2005 | US20050228039 Luminacin analogs and uses thereof |
| 10/13/2005 | US20050226940 Antitumour compositions containing taxane derivatives |
| 10/13/2005 | US20050224757 E.g., 3-fluoro-4-(trifluoromethoxy)phenyl p-(6-(3-ethyl-3-oxetanylmethoxy)hexyloxy)benzoate; exhibits nematic hybrid orientation on a rubbed cellulose triacetate substrate |
| 10/12/2005 | EP1109798B1 Geranic acid derivatives |
| 10/12/2005 | CN1681799A Taxane derivatives functionalized at the 14- position and a process for the preparation thereof |
| 10/12/2005 | CN1680348A Separation of taxinol from cephalotaxin |
| 10/12/2005 | CN1680347A Synthesis of 3, 6-dialkyl-5, 6-dihydro-4-hydroxy-pyran-2-ketone |
| 10/12/2005 | CN1680346A Apparatus and method for monotubular multi-spiral static mixed tube style chlorohydrination of propene for production of epoxypropane |
| 10/12/2005 | CN1679937A Compositions and methods for treating or preventing inflammatory diseases |
| 10/11/2005 | US6953862 Oxetane compounds containing styrenic functionality |
| 10/06/2005 | US20050222438 Reacting aqueous ascorbic acid or isoascorbic acid solution with calcium nitrite in reaction vessel |
| 10/06/2005 | US20050222155 Inhibitors of akt activity |
| 10/06/2005 | US20050222089 taxane is prepared by esterifying an appropriate baccatin carrying a C-13 hydroxyl functional group with an acid derivative and is obtained by controlled saponification |
| 10/06/2005 | DE102004002875A1 Katalysator zur Carbonylierung von Oxiranen A catalyst for carbonylation of oxiranes |
| 10/05/2005 | EP1582210A2 Compositions and methods for treating or preventing surgical adhesions |
| 10/05/2005 | CN1221539C Taxane derivs |
| 10/04/2005 | CA2152771C 7-o-ethers of taxane derivatives |
| 09/29/2005 | WO2005044811A3 Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin iii |
| 09/28/2005 | CN1675179A Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography |
| 09/28/2005 | CN1220692C Process for preparing cephalotaxane derivatives |
| 09/22/2005 | WO2005087710A1 Aminophenylpropanoic acid derivative |
| 09/22/2005 | WO2005087222A1 C7 lactyloxy-substituted taxanes |
| 09/22/2005 | US20050209468 Solvent extraction; using mixture of alcohol and fluorinated solvent; separation |
| 09/22/2005 | US20050209311 C7 lactyloxy-substituted taxanes |
| 09/22/2005 | US20050209174 Especially conjugating derivatives of paclitaxel, cholesterol, camptothecin, and rhodamine123 to transferrins, side effect reduction |
| 09/22/2005 | US20050208137 comprising angiogenesis inhibitor retinoic acid, taxol and polymeric carrier polylactone; treating cancer, angiogenic-dependent diseases, embolizing blood vessels, and eliminating biliary, urethral, esophageal, tracheal/bronchial obstructions, corneal neovascularization; coated stents with the mixture |
| 09/22/2005 | CA2560111A1 Aminophenylpropanoic acid derivative |
| 09/21/2005 | EP1575929A1 The method for production of semi-finished products useful in synthesis of paclitaxel |
| 09/21/2005 | CN1670018A Process for preparing taxol |
| 09/13/2005 | US6943258 Polymer compounds containing oxetane and cinnamyl functionality |
| 09/09/2005 | WO2005082875A2 Semi-synthesis of taxane intermediates and aziridine analogues and their conversion to paclitaxel and docetaxel |
| 09/06/2005 | US6939978 Production of taxol and taxanes |
| 09/01/2005 | WO2005080366A1 Alkyl carbamate-substituted butyrolactones serving as lipase inhibitors |
| 09/01/2005 | WO2005080365A1 Process for producing 2,2,3,3-tetrafluorooxetane |
| 09/01/2005 | WO2005080364A1 Process for producing alicyclic oxetane compound |
| 09/01/2005 | WO2005080322A1 Fluorene derivative |
| 09/01/2005 | WO2005079398A2 Drug conjugates |
| 09/01/2005 | US20050192446 3-isopropenyl-a,a-dimethyl-benzylcarbamate ethyl (or methyl) oxetane; oxetane functionality is homopolymerizable in reactions that undergo cationic or anionic ring opening; styrenic is polymerizable with compounds such as electron acceptors |
| 09/01/2005 | US20050192445 Semi-synthesis of taxane intermediates and aziridine analogues and their conversion to paclitaxel and docetaxel |
| 09/01/2005 | US20050191367 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors |
| 09/01/2005 | CA2560446A1 Alkyl carbamate-substituted butyrolactones serving as lipase inhibitors |
| 09/01/2005 | CA2555641A1 Drug conjugates |
| 09/01/2005 | CA2537079A1 Fluorene derivative |
| 08/31/2005 | CN1662592A Low acidity phosphate esters |
| 08/31/2005 | CN1660827A Method for elementary separating 10-noracetyl Baccatins III from branches and leaves of yew |
| 08/25/2005 | WO2005077984A1 Process for producing organic compound and antibody for use therein |
| 08/25/2005 | WO2004074810A3 Signalling compounds for use in methods of detecting hydrogen peroxide |
| 08/25/2005 | US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability; |
| 08/18/2005 | WO2005075445A2 (meth) acryloyl group-containing oxetane compound and production method thereof |
| 08/18/2005 | US20050182098 Administering taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions for inhibiting tumor growth |
| 08/18/2005 | US20050182035 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease, cancer, skin disorders, immune system disorders, asthma, hypertension, hypothyroidism, hypocalcemia, female infertility and alopecia |
| 08/18/2005 | US20050182034 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 08/17/2005 | EP1564200A1 Ketone compounds and compositions for cholesterol management and related uses |
| 08/17/2005 | EP1562927A2 Thio-analogues of paclitaxel and intermediates thereof |
| 08/17/2005 | EP1389196A4 Three-step conversion of protected taxane ester to paclitaxel |
| 08/16/2005 | CA2347588C An oxazinone used in preparing taxol and process for preparation thereof |
| 08/11/2005 | WO2005073209A1 Method for the preparation of synthesized taxanoids |
| 08/11/2005 | US20050176975 Selective acylation of secondary hydroxyl groups |
| 08/10/2005 | EP1497276A4 Conversion of taxane molecules |
| 08/10/2005 | EP1383754A4 Process for making taxane derivatives |
| 08/10/2005 | EP1301499A4 Stable isotope labeling of paclitaxel |
| 08/10/2005 | CN1651421A Method of producing propylene oxide by direct oxidation of propylene |
| 08/03/2005 | EP1558243A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 08/03/2005 | CN1648132A Taxinol water soluble derivative |
| 08/03/2005 | CN1213042C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 07/28/2005 | WO2005068449A1 Catalyst for the carbonylation of oxiranes |
| 07/28/2005 | WO2005068420A1 Urea and thiourea compounds and compositions for cholesterol management and related uses |
| 07/28/2005 | WO2005068418A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 07/28/2005 | WO2005068412A1 Ketone compounds and compositions for cholesterol management and related uses |
| 07/28/2005 | WO2005068410A1 Ether compounds and compositions for cholesterol management and related uses |
| 07/28/2005 | US20050165051 Taxanes having a C7 carbonate substituent |
| 07/28/2005 | US20050164995 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 07/28/2005 | US20050163707 Radio labelled monoclonal antibody human milk fat globule1, binds selectively to polymorphic epithelial mucin; Taxotere chemotherapeutic agent; administered in combination |
| 07/27/2005 | EP1556030A2 Taxane metabolites |
| 07/27/2005 | EP1470117B1 Methylenelactone synthesis in supercritical fluids |
| 07/27/2005 | CN1646512A A semi-synthetic process for the preparation of N debenzoylpaclitaxel |
| 07/21/2005 | US20050159606 Fluorescent dye-fused lactone derivative covalently attaches to biological agent; xanthene or phenoxazine derivatives; chroman-2-one dyes; phosphoramidite linkages |
| 07/20/2005 | CN1640871A Preparation process for synthesized taxane |
| 07/19/2005 | US6919463 A boronate derivatives, reacting with a source of hydrogen peroxide to produce a colorimetric, fluorescent, chemiluminescent or bioluminescent product, detecting enzymes which generate hydrogen peroxide, quantitative analysis |
| 07/14/2005 | WO2005063729A1 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| 07/14/2005 | WO2005030150A3 9,10-α,α-OH-TAXANE ANALOGS AND METHODS FOR PRODUCTION THEREOF |
| 07/14/2005 | US20050154218 Method for purification of paclitaxel from paclitaxel-containing materials |
| 07/14/2005 | US20050154217 Amorphous polyether glycols based on bis-substituted oxetane and tetrahydrofuran monomers |
| 07/14/2005 | CA2551610A1 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| 07/13/2005 | CN1638797A Cancer treatment |
| 07/13/2005 | CN1637011A Avermectin derivatives |
| 07/12/2005 | US6916942 Process for the preparation of C-4 carbonate taxanes |
| 07/07/2005 | WO2005061474A1 Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions |
| 07/07/2005 | US20050148657 9, 10-Alpha, alpha-OH-taxane analogs and methods for production thereof |
| 07/06/2005 | EP1550659A1 Method for purification of paclitaxel from paclitaxel-containing materials |
| 07/06/2005 | EP1549628A2 Method of preparing amino acid taxane derivatives and polymer conjugates containing the same |
| 07/06/2005 | CN1634902A Clean preparation process for hexafluropropylene oxide |
| 06/30/2005 | WO2005040357A3 Compounds and methods for fluorescent labeling |
| 06/30/2005 | US20050143447 Mixing at least one nonaqueous, pharmaceutically acceptable solvent and a taxane compound |
| 06/30/2005 | US20050143446 Compounds for use as antigrowth agents or antitumor agents and with solvents |
| 06/29/2005 | EP1545773A1 Catalyst and method for the carbonylation of oxiranes |
| 06/28/2005 | US6911549 Method of preparing a taxol derivative |